Trimethoprim-sulfamethoxazole: absorption, excretion, and toxicity in six children.
D000380:Agranulocytosis / Q000139:chemically induced; D001424:Bacterial Infections / Q000188:drug therapy; D002353:Carrier State / Q000188:drug therapy; D002648:Child; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D016030:Kidney Transplantation; D010033:Otitis Media / Q000188:drug therapy; D011014:Pneumonia / Q000188:drug therapy; D013420:Sulfamethoxazole / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000378:metabolism* / Q000652:urine; D013530:Surgical Wound Infection / Q000188:drug therapy; D014184:Transplantation, Homologous; D014295:Trimethoprim / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000378:metabolism* / Q000652:urine; D014552:Urinary Tract Infections / Q000188:drug therapy
D004338:Drug Combinations; D007166:Immunosuppressive Agents; D014295:Trimethoprim; D013420:Sulfamethoxazole